Condensed Consolidated Statements of Cash Flows (unaudited) (USD $) In Thousands	3 Months Ended
	Oct. 02, 2011	Sep. 26, 2010
Cash flows from operating activities:
Net income	$ 1,583	$ 2,712
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Decrease in accrued investment income	961	315
Depreciation and amortization	1,341	1,539
Amortization of intangible assets	519	503
Change in value / loss on value of UBS option to put securities	0	2,429
Auction rate securities mark to market, trading gain	0	(2,429)
Provision for doubtful accounts	(140)	0
Excess and obsolete inventory	37	11
Deferred income taxes	7	(709)
Stock-based compensation	1,895	2,109
Unrealized (gain)/loss on foreign exchange	(366)	(1,187)
Changes in operating assets and liabilities, net
Accounts receivable	5,191	2,394
Inventories	(1,468)	1,343
Prepaid expenses and other assets	4,203	(1,544)
Accounts payable	(2,909)	(1,214)
Accrued compensation and benefits	(2,505)	(582)
Restructuring liabilities	(1,406)	(912)
Accrued warranty	62	(376)
Deferred revenue, net	(786)	(1,173)
Deferred distributors revenue, net of cost of sales to distributors	(4,554)	(2,921)
Other accrued liabilities	(5,579)	3,325
Other long-term liabilities	(30)	(2,481)
Net cash (used in) provided by operating activities	(3,944)	1,152
Cash flows used in investing activities:
Capital expenditures	(748)	(1,362)
Purchases of investments	(21,096)	(43,541)
Proceeds from maturities of investments and marketable securities	10,300	5,800
Proceeds from sales of investments and marketable securities	9,915	33,144
Net cash used in investing activities	(1,629)	(5,959)
Cash flows provided by financing activities:
Proceeds from issuance of common stock	620	86
Net cash provided by financing activities	620	86
Foreign currency effect on cash	(805)	342
Net decrease in cash and cash equivalents	(5,758)	(4,379)
Cash and cash equivalents at beginning of period	49,972	51,944
Cash and cash equivalents at end of period	$ 44,214	$ 47,565